# Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery

> **NCT01007955** · — · COMPLETED · sponsor: **University of Massachusetts, Worcester** · enrollment: 61 (actual)

## Conditions studied

- Morbid Obesity
- Insulin Resistance
- Non-Alcoholic Fatty Liver Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01007955
- **Lead sponsor:** University of Massachusetts, Worcester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01007955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01007955, "Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01007955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*